A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children With Autistic Disorder and Other Pervasive Developmental Disorders (PDD)

• Status: Completed
• Trial end date: 2001-12-01

Summary

The purpose of the study is to evaluate the effectiveness of an oral solution of risperidone (an antipsychotic medication) versus placebo in the treatment of behavioral symptoms in children with Pervasive Developmental Disorders (PDD).

• Phase: Phase 3

Details

• Lead Sponsor: Janssen-Ortho Inc., Canada
• Treatments: Risperidone